-
6
-
-
15444353262
-
-
Y. Sakai T. Yoshida T. Tsujita K. Ochiai T. Agatsuma Y. Saitoh F. Tanaka T. Akiyama S. Akinaga T. Mizukami J. Antibiot. 1997 50 659
-
(1997)
J. Antibiot.
, vol.50
, pp. 659
-
-
Sakai, Y.1
Yoshida, T.2
Tsujita, T.3
Ochiai, K.4
Agatsuma, T.5
Saitoh, Y.6
Tanaka, F.7
Akiyama, T.8
Akinaga, S.9
Mizukami, T.10
-
7
-
-
0032510429
-
-
K. Umezawa K. Nakazawa T. Uemura Y. Ikeda S. Kondo H. Naganawa N. Kinoshita H. Hashizume M. Hamada T. Takeuchi S. Ohba Tetrahedron Lett. 1998 39 1389
-
(1998)
Tetrahedron Lett.
, vol.39
, pp. 1389
-
-
Umezawa, K.1
Nakazawa, K.2
Uemura, T.3
Ikeda, Y.4
Kondo, S.5
Naganawa, H.6
Kinoshita, N.7
Hashizume, H.8
Hamada, M.9
Takeuchi, T.10
Ohba, S.11
-
11
-
-
0025014543
-
-
P. L. Durette F. Baker P. L. Barker J. Boger S. S. Bondy M. L. Hammond T. J. Lanza A. A. Pessolano C. G. Caldwell Tetrahedron Lett. 1990 31 1237
-
(1990)
Tetrahedron Lett.
, vol.31
, pp. 1237
-
-
Durette, P.L.1
Baker, F.2
Barker, P.L.3
Boger, J.4
Bondy, S.S.5
Hammond, M.L.6
Lanza, T.J.7
Pessolano, A.A.8
Caldwell, C.G.9
-
13
-
-
0141712450
-
-
K. B. Sharpless W. Amberg Y. L. Bennani G. A. Crispino J. Hartung K.-S. Jeong H.-L. Kwong K. Morikawa Z.-M. Wang D. Xu X.-L. Zhang J. Org. Chem. 1992 57 2768
-
(1992)
J. Org. Chem.
, vol.57
, pp. 2768
-
-
Sharpless, K.B.1
Amberg, W.2
Bennani, Y.L.3
Crispino, G.A.4
Hartung, J.5
Jeong, K.-S.6
Kwong, H.-L.7
Morikawa, K.8
Wang, Z.-M.9
Xu, D.10
Zhang, X.-L.11
-
15
-
-
0003544583
-
-
I. Ojima, VCH Publishers, New York, 2nd edn, pp. 357
-
R. A. Johnson and K. B. Sharpless, Catalytic Asymmetric Synthesis, ed., I. Ojima, VCH Publishers, New York, 2nd edn, 2000, pp. 357
-
(2000)
Catalytic Asymmetric Synthesis, Ed.
-
-
Johnson, R.A.1
Sharpless, K.B.2
-
42
-
-
0030025106
-
-
K. J. Hale J. Cai V. Delisser S. Manaviazar S. A. Peak G. S. Bhatia T. C. Collins N. Jogiya Tetrahedron 1996 52 1047
-
(1996)
Tetrahedron
, vol.52
, pp. 1047
-
-
Hale, K.J.1
Cai, J.2
Delisser, V.3
Manaviazar, S.4
Peak, S.A.5
Bhatia, G.S.6
Collins, T.C.7
Jogiya, N.8
-
47
-
-
77953208670
-
-
Division of Organic Chemistry, pp. 10-15, Abstract 119
-
P. L. Durette, F. Baker, P. L. Barker, J. Boger, S. S. Bondy, M. L. Hammond, T. L. Lanza, A. A. Pessolano and C. G. Caldwell, Abstracts of 198th American Chemical Society National Meeting, Division of Organic Chemistry, 1989, pp. 10-15, Abstract 119
-
(1989)
Abstracts of 198th American Chemical Society National Meeting
-
-
Durette, P.L.1
Baker, F.2
Barker, P.L.3
Boger, J.4
Bondy, S.S.5
Hammond, M.L.6
Lanza, T.L.7
Pessolano, A.A.8
Caldwell, C.G.9
-
73
-
-
60849096395
-
-
K. J. Hale S. Manaviazar L. Lazarides J. George M. A. Walters J. Cai V. M. Delisser G. S. Bhatia S. A. Peak S. M. Dalby A. Lefranc Y.-N. Chen A. W. Wood P. Crowe P. Erwin M. El-Tanani Org. Lett. 2009 11 737
-
(2009)
Org. Lett.
, vol.11
, pp. 737
-
-
Hale, K.J.1
Manaviazar, S.2
Lazarides, L.3
George, J.4
Walters, M.A.5
Cai, J.6
Delisser, V.M.7
Bhatia, G.S.8
Peak, S.A.9
Dalby, S.M.10
Lefranc, A.11
Chen, Y.-N.12
Wood, A.W.13
Crowe, P.14
Erwin, P.15
El-Tanani, M.16
-
81
-
-
0028901512
-
-
For examples of other much less potent β-catenin/TCF4-protein small molecule disrupters, see:
-
P. W. Hinds Curr. Opin. Genet. Dev. 1995 5 79
-
(1995)
Curr. Opin. Genet. Dev.
, vol.5
, pp. 79
-
-
Hinds, P.W.1
-
82
-
-
1642512639
-
-
M. Lepourcelet Y.-N. Chen D. S. France H. Wang P. Crews F. Petersen C. Bruseo A. W. Wood R. A. Shivdasani Cancer Cell 2004 5 91
-
(2004)
Cancer Cell
, vol.5
, pp. 91
-
-
Lepourcelet, M.1
Chen, Y.-N.2
France, D.S.3
Wang, H.4
Crews, P.5
Petersen, F.6
Bruseo, C.7
Wood, A.W.8
Shivdasani, R.A.9
-
83
-
-
76349103549
-
-
For an alternative way of inhibiting β-catenin/TCF4 mediated gene transcription within human cancer cells by downregulation of β-catenin expression with (-)-agelastatin A, see:
-
M. Ishibashi M. A. Arai J. Synth. Org. Chem. Jpn. 2009 67 1094
-
(2009)
J. Synth. Org. Chem. Jpn.
, vol.67
, pp. 1094
-
-
Ishibashi, M.1
Arai, M.A.2
-
84
-
-
41649087976
-
-
C. K. Mason S. McFarlane P. G. Johnston P. Crowe P. J. Erwin M. M. Domostoj F. C. Campbell S. Manaviazar K. J. Hale M. El-Tanani Mol. Cancer Ther. 2008 7 548
-
(2008)
Mol. Cancer Ther.
, vol.7
, pp. 548
-
-
Mason, C.K.1
McFarlane, S.2
Johnston, P.G.3
Crowe, P.4
Erwin, P.J.5
Domostoj, M.M.6
Campbell, F.C.7
Manaviazar, S.8
Hale, K.J.9
El-Tanani, M.10
-
86
-
-
28844503703
-
-
P. Dimopoulos A. Athlan S. Manaviazar J. George M. Walters L. Lazarides A. E. Aliev K. J. Hale Org. Lett. 2005 7 5369
-
(2005)
Org. Lett.
, vol.7
, pp. 5369
-
-
Dimopoulos, P.1
Athlan, A.2
Manaviazar, S.3
George, J.4
Walters, M.5
Lazarides, L.6
Aliev, A.E.7
Hale, K.J.8
-
96
-
-
77953220364
-
-
University of London
-
J. George, PhD Thesis, University of London, 2007
-
(2007)
-
-
George Phd Thesis, J.1
-
108
-
-
0037198760
-
-
For a synthetic study on the synthesis of the GE3 acyl side-chain, see:
-
K. J. Hale L. Lazarides Org. Lett. 2002 4 1903
-
(2002)
Org. Lett.
, vol.4
, pp. 1903
-
-
Hale, K.J.1
Lazarides, L.2
-
110
-
-
0036967913
-
-
4-Epi-A83586C was originally prepared from 116 by macrocyclisation with an excess of BOP and DMAP, which caused complete and total epimerisation at the original (3S)-Piz centre of 116 during the ring-closure event. For more details of this novel reaction, as well as an independent full total synthesis of 4-epi-A83586C see:
-
K. J. Hale L. Lazarides Chem. Commun. 2002 1832
-
(2002)
Chem. Commun.
, pp. 1832
-
-
Hale, K.J.1
Lazarides, L.2
-
115
-
-
0037096898
-
-
P. S. Rudland A. Platt-Higgins M. El-Tanani D. DeSilva Rudland R. Barraclough J. H. Winstanley R. Howitt C. R. West Cancer Res. 2002 62 3417
-
(2002)
Cancer Res.
, vol.62
, pp. 3417
-
-
Rudland, P.S.1
Platt-Higgins, A.2
El-Tanani, M.3
Desilva Rudland, D.4
Barraclough, R.5
Winstanley, J.H.6
Howitt, R.7
West, C.R.8
|